Carey Ng's most recent trade in Immix Biopharma Inc was a trade of 10,000 Common Stock done at an average price of $1.9 . Disclosure was reported to the exchange on Aug. 16, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Immix Biopharma Inc | Carey Ng | Director | Purchase of securities on an exchange or from another person at price $ 1.86 per share. | 16 Aug 2024 | 10,000 | 20,000 | - | 1.9 | 18,600 | Common Stock |
Immix Biopharma Inc | Carey Ng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 33,000 | 33,000 | - | - | Stock Option (Right to Buy) | |
Immix Biopharma Inc | Carey Ng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 25,512 | 25,512 | - | - | Stock Option (Right to Buy) | |
Immix Biopharma Inc | Carey Ng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 21,587 | 21,587 | - | - | Stock Option (Right to Buy) | |
Immix Biopharma Inc | Carey Ng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 20,000 | 20,000 | - | - | Stock Options | |
Immix Biopharma Inc | Carey Ng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 16,000 | 16,000 | - | - | Stock Options | |
Immix Biopharma Inc | Carey Ng | Director | 20 Dec 2021 | 1,000,221 | 1,000,221 | - | 0.9 | 850,188 | Common Stock | |
Immix Biopharma Inc | Carey Ng | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 20 Dec 2021 | 25,000 | 1,025,221 | - | 5 | 125,000 | Common Stock |